FDA Drug Application (076177) for CAMILA by MAYNE PHARMA

Back to FDA Applications sponsored by MAYNE PHARMA

Application Number076177
Product Number001
FormTABLET;ORAL-28
Dosage0.35MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCAMILA
Active IngredientNORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by MAYNE PHARMA